Medical Director, Medical Oncology Programs and Genetics
Dr. Fisch is the Medical Director of Medical Oncology Programs and Genetics for AIM. A full-time clinical leader since 2015, he works closely with the executive leadership team to provide clinical expertise for the expansion of the AIM Medical Oncology Solution and for the AIM Genetic Testing Solution.
In addition to his role at AIM, Dr. Fisch is a part-time clinical professor at MD Anderson Cancer Center in Houston. His faculty career at MD Anderson began in the Department of Palliative Care and Rehabilitation in 1999. He then led the MD Anderson Community Clinical Oncology Program (CCOP) Research Base and subsequently served as the founding chair of the Department of General Oncology. In the latter role, Dr. Fisch led a group of clinical faculty involved in clinical and basic research and the management of patients in community and academic settings.
Throughout his career, Dr. Fisch has held numerous national service roles. Currently, he is a co-chair of the SWOG Symptom Control and Quality of Life Committee and a member of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC). From 2007 to 2014, he co-chaired the NCI Symptom Management and Quality of Life Committee. He also served as chair of the Eastern Cooperative Oncology Group and the American College of Radiology Imaging Network (ECOG-ACRIN) Symptom Science and Treatment Toxicity Committee, the SWOG Social Media Working Group, and the first American Society of Clinical Oncology (ASCO) Palliative Care in Oncology Symposium.
Dr. Fisch completed his undergraduate, medical school, and internal medicine training at the University of Virginia, and his hematology/oncology fellowship training at Indiana University. He also received his master’s in public health at Indiana University. He is board-certified in medical oncology, internal medicine, and hospice and palliative medicine, and has been honored by election to fellowship by the professional societies in each of these disciplines.